文献速递主动脉疾病

定制开窗Anaconda主动脉支架的术中及1年结局:英国多中心研究

Operative and 1-Year Outcomes of the Custom-Made Fenestrated Anaconda Aortic Stent Graft-A UK Multicenter Study.
PubMed 文献 · Ann Vasc Surg · 2017-06-12

该多中心回顾性研究纳入英国4个中心2010至2014年首批101例择期复杂主动脉瘤开窗腔内修复(FEVAR)病例,评估定制开窗Anaconda支架的临床结局。结果显示围术期死亡率为3%,30天随访靶血管通畅率达98.4%,1个月和1年生存率分别为97%和91%。

要点

  • 定制开窗Anaconda支架围术期死亡率低(3%),30天靶血管通畅率高(98.4%)。
  • 完成造影时发现的10例Ia型内漏均自行消退,1年随访仅1例瘤囊扩张。

核心结论

  • 定制开窗Anaconda支架在复杂主动脉瘤的FEVAR中表现出较低的围术期死亡率和较高的30天及1年技术与临床成功率。

研究设计与样本

  • 英国4个中心2010至2014年首批101例择期开窗腔内修复病例的回顾性、中心上报数据分析。
  • 共植入101枚开窗支架,中位年龄76岁,男性占85%。

主要发现

  • 共使用255个开窗(196个肾动脉、48个肠系膜上动脉、11个腹腔干),围术期死亡率为3%。
  • 30天随访靶血管通畅率为98.4%,完成造影时发现15例I型或III型内漏,其中10例Ia型内漏均自行消退。
  • Kaplan-Meier分析1个月和1年生存率分别为97%和91%,75.8%患者腹主动脉瘤直径缩小,仅1例瘤囊扩张。
  • 免于靶血管通畅丧失的比例为97.6%。

临床怎么用

  • 对于复杂主动脉瘤行FEVAR,定制开窗Anaconda支架可作为低围术期死亡率和良好短期通畅性的治疗选择。
  • 术后需关注I型内漏,尤其是Ia型内漏有自行消退可能,但仍需随访瘤囊变化。

局限性

  • 为回顾性、中心上报数据,样本仅101例且来自4个中心,随访时间限于1年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early and 1-year outcomes are presented for fenestrated endovascular aneurysm repair (FEVAR) of complex aortic aneurysmal disease with the custom-made Anaconda fenestrated stent graft in 101 patients. METHODS: Retrospective site-reported data from the first 101 elective cases (2010-2014) from 4 UK centers were studied to evaluate patient demographics, aneurysm morphology, clinical success, and 1-year outcomes in patients undergoing fenestrated aneurysm repair with the custom-made Anaconda device. RESULTS: 101 fenestrated grafts (median age 76, 85% male) were implanted with a total of 255 fenestrations (196 renal arteries, 48 superior mesenteric artery, and 11 celiac arteries) with 3% mortality, 98.4% target vessel patency (TVP) at 30 day follow-up. Although 15 type I or III endoleaks were demonstrated at completion angiography, all 10 type Ia endoleaks resolved spontaneously. Survival by Kaplan-Meier analysis was 97% and 91% at 1 month and 1 year, respectively; with 75.8% showing reduction in abdominal aortic aneurysm diameter and only 1 patient with sac expansion. Freedom from loss of TVP was 97.6%. CONCLUSIONS: Custom-made fenestrated Anaconda devices demonstrate low procedural mortality and a high rate of technical and clinical success at 30 days and 1 year.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Colgan FE, Bungay PM, Burfitt N, et al. Operative and 1-Year Outcomes of the Custom-Made Fenestrated Anaconda Aortic Stent Graft-A UK Multicenter Study. Ann Vasc Surg. 2017. PMID: 28619356. doi:10.1016/j.avsg.2017.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。